This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Acadia Pharmaceuticals Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovations of James M Youakim
Introduction
James M Youakim is a notable inventor based in Bryn Mawr, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease psychosis. His innovative approach has led to the development of a patent that addresses critical symptoms associated with dementia.
Latest Patents
James M Youakim holds a patent for "Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis." This patent outlines methods for treating Alzheimer's disease psychosis, including the administration of pimavanserin. The patent also details methods for treating delusions and hallucinations in individuals with dementia, as well as reducing agitated or aggressive behavior in these patients. His work is pivotal in enhancing the quality of life for those affected by Alzheimer's disease.
Career Highlights
Youakim is associated with Acadia Pharmaceuticals Inc., where he continues to contribute to advancements in pharmaceutical treatments. His dedication to research and innovation has positioned him as a key figure in the development of therapies for neurodegenerative diseases.
Collaborations
James M Youakim has collaborated with notable colleagues, including Bruce Duane Coate and James Randall Owen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of Alzheimer's research.
Conclusion
James M Youakim's contributions to the treatment of Alzheimer's disease psychosis through his innovative patent demonstrate his commitment to improving patient care. His work continues to inspire advancements in medical research and treatment methodologies.